Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis.
- DOI
- 10.1016/j.jcf.2019.08.020
- Published
- 2020 Mar
- Container
- Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jcf.2019.08.020,
title = {Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis.},
author = {Barth P and Bruijnzeel P and Wach A and Sellier Kessler O and Hooftman L and Zimmermann J and Naue N and Huber B and Heimbeck I and Kappeler D and Timmer W and Chevalier E},
year = {2020},
journal = {Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society},
doi = {10.1016/j.jcf.2019.08.020},
url = {https://doi.org/10.1016/j.jcf.2019.08.020}
}RIS
TY - JOUR TI - Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis. AU - Barth P AU - Bruijnzeel P AU - Wach A AU - Sellier Kessler O AU - Hooftman L AU - Zimmermann J AU - Naue N AU - Huber B AU - Heimbeck I AU - Kappeler D AU - Timmer W AU - Chevalier E PY - 2020 JO - Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society DO - 10.1016/j.jcf.2019.08.020 UR - https://doi.org/10.1016/j.jcf.2019.08.020 ER -
APA
P, B., P, B., A, W., O, S. K., L, H., J, Z., N, N., B, H., I, H., D, K., W, T., & E, C. (2020). Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis.. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. https://doi.org/10.1016/j.jcf.2019.08.020
Source records
- pubmed · retrieved 2026-09-24T20:44:34.867Z